Journal
Contemporary Clinical Trials Communications
Publication Date
12-1-2023
Volume
36
First Page
101208
Document Type
Open Access Publication
DOI
10.1016/j.conctc.2023.101208
Rights and Permissions
Coggan AR, Park LK, Racette SB, Davila-Roman VG, Lenzen P, Vehe K, Dore PM, Schechtman KB, Peterson LR. The inorganic NItrate and eXercise performance in Heart Failure (iNIX-HF) phase II clinical trial: Rationale and study design. Contemp Clin Trials Commun. 2023 Oct 2;36:101208. doi: 10.1016/j.conctc.2023.101208. © 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Recommended Citation
Coggan, Andrew R; Park, Lauren K; Racette, Susan B; Davila-Roman, Victor G; Lenzen, Pattie; Vehe, Kathryn; Dore, Peter M; Schechtman, Kenneth B; and Peterson, Linda R, "The inorganic NItrate and eXercise performance in Heart Failure (iNIX-HF) phase II clinical trial: Rationale and study design." Contemporary Clinical Trials Communications. 36, 101208 (2023).
https://digitalcommons.wustl.edu/oa_4/2604
Department
ICTS (Institute of Clinical and Translational Sciences)
